Furadantin in urinary-tract infections; clinical and laboratory studies.

作者: Howard M. Trafton , Ernst H. Beutner , John J. Petronio , Howard E. Lind , Manuel Correia-Branco

DOI: 10.1056/NEJM195503102521003

关键词:

摘要: ANUMBER of infections encountered in urologic practice, primarily those due to Proteus vulgaris and Pseudomonas aeruginosa, are resistant many antibiotic chemotherapeutic agents. Furadantin,** a more recent agent, has shown considerable promise as urinary antiseptic.1 2 3 4 5 6 7 8 9 10 According available reports, this drug is effective both gram-positive grami-negative organisms, including P. vulgaris. However, Furadantin not been sufficiently evaluated permit definitive conclusions regarding its antibacterial spectrum, long-range clinical effectiveness patient tolerance. The present paper concerns further study the antiseptic. Findings summarized correlated . . .

参考文章(2)
AKSEL STENDERUP, FLEMMING KISSMEYER-NIELSEN, PEDER LINNET-JEPSEN, Chemotherapy in Infections of the Urinary Tract Acta Medica Scandinavica. ,vol. 144, pp. 124- 136 ,(2009) , 10.1111/J.0954-6820.1952.TB15677.X
William E. Schatten, Lester Persky, Furadantin in the therapy of genitourinary tract infections American Journal of Surgery. ,vol. 86, pp. 720- 722 ,(1953) , 10.1016/0002-9610(53)90384-5